Magnetic resonance imaging in renal transplantation by Neimatallah, Mohammed A. et al.
Original Research
Magnetic Resonance Imaging in Renal
Transplantation
Mohammed A. Neimatallah, MB, ChB,* Qian Dong, MD, Stefan O. Schoenberg, MD,
Kyung J. Cho, MD, and Martin R. Prince, MD, PhD
End stage renal disease is common and can result from a
variety of diseases. The expense and morbidity of dialysis
has made renal transplantation the preferred treatment
when it is available. In the United States, 11,000 renal
transplants are performed annually. Because of the limited
supply of donor organs, every effort is made to salvage the
transplanted kidney that has began to fail. Imaging mo-
dalities that are currently used to evaluate transplanted
kidneys are ultrasound (US), computed tomography (CT),
scintigraphy, intravenous urography (IVU), contrast angiog-
raphy, and magnetic resonance imaging (MRI). MRI offers
multiple advantages. MRI provides cross sectional and
vascular information without the risks of ionizing radia-
tion, iodinated contrast, or arterial catheterization. This
article describes the role of MR imaging in renal transplanta-
tion, technical aspects of image acquisition, and MR findings
ofpost-transplantationcomplications. J.Magn.Reson. Imag-
ing 1999;10:357–368. r 1999 Wiley-Liss, Inc.
MR IMAGING OF POTENTIAL DONORS
Since there is increased complexity of surgery and
potential risk to the donor kidney during surgery when
there are anatomic variations, pretransplantation as-
sessment of the renal vascular anatomy of the potential
renal donor is an important step (2–7). The incidence of
variant arterial anatomy of the kidney is 40%, including
early renal artery division or branches, multiple renal
arteries (aberrant and accessory renal arteries), and
multiple renal veins. Multiple renal arteries occur in
30% of the population (8). Angiography has been the
primary imaging modality for the evaluation of renal
vascular anatomy. In addition to finding accessory
renal arteries and renal arterial pathology, angiography
obtains information about the length of the main renal
artery before division. A length of at least 2 cm is
preferred for surgical anastomosis (9,11). Although con-
ventional angiography is the gold standard it is an
invasive procedure. Because of the risks of allergic
reaction, nephrotoxicity from the use of iodinated con-
trast, hematoma, intimal wall injury, and thrombosis,
non-invasive imaging methods are preferred.
In the last few years, 3D-Gd MRA has advanced to the
point that most of renal vascular anatomy can be
accurately demonstrated (Fig. 1). Recent studies have
reported excellent sensitivity and accuracy in the depic-
tion of accessory renal arteries, using conventional
angiography as the standard of reference (2,3,10–13).
MRI also has the advantage of assessing the donor renal
parenchyma for masses or cysts. CT angiography is also
promising for evaluation of renal donors, although it
does not eliminate the risk of iodinated contrast nor
ionizing radiation.
Using MR hydrography (SSFSE 5 single shot fast
spin echo, HASTE 5 half Fourier single shot turbo spin
echo) or 3D contrast-enhanced MRU, it is possible to
assess the collecting system as well as the ureters. Low
et al. reported a comprehensive MR examination for the
potential renal transplant donor, including 3D enhanced-
MRA, MR urography, and MR nephrography (3).
SURGICAL ASPECTS OF RENAL
TRANSPLANTATION
Knowledge of the surgical anatomy of the renal allograft
and its post surgical complications is fundamental for
imaging of the renal allograft. There are several surgical
approaches to renal transplantation: the standard pel-
vic approach (intra or extraperitoneal), pediatric en-bloc
approach, lower abdominal approach (if there have
been more than two prior transplants), and orthotopic
approach (Fig. 2a–c).
The donor left kidney is preferred when there are no
anomalies because the longer left renal vein facilitates
the venous anastomosis (14). Simultaneous kidney-
pancreas transplantation is a preferred option for treat-
ing end stage renal disease in patients with type I
diabetes mellitus (Fig. 3) (1).
MR IMAGING TECHNIQUES
MRI has a variety of sequences that can obtain informa-
tion about anatomy, function, flow, and lesion charac-
terization. The pelvic location of the renal allograft
minimizes motion artifact related to respiration particu-
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larly if the torso coil is secured tight around the pelvis to
restrict abdominal wall motion. Administration of anti-
spasmodic drugs such as glucagon or Hyosen-N-
butylbromide (buscopan) can be helpful in improving
the image quality by reducing the bowel motion. Previ-
ous abdominal and pelvic radiographs should be re-
viewed for the presence of surgical clips in the trans-
plant region since this may produce confusing metallic
artifact (15). Prior to the examination, the patient is
rested in a quite room for relaxation. In claustrophobic
patients, mild sedation may be required. In adult pa-
tients, 5–10 mg of diazepam or 1–2 mg Xanay is given
orally 20–30 minutes before the examination. An 18 or
20 gauge angiocatheter is inserted in the antecubital
Figure 1. Coronal MIP reconstruction of breath-hold 3D Gd-MRA. Bilateral accessory renal arteries arising from the abdominal aorta.
Figure 2. Illustrations showing different surgical approaches to renal transplantation. Basic pelvic approach (a), Orthotopic (b),
and pediatric En-block approach (c).
358 Neimatallah et al.
vein and connected to the tubing set flushed with saline
ready for contrast injection.
Imaging begins with a large field-of-view coronal loca-
tor sequence such as Single Shot Fast Spin Echo
(SSFSE) or T1 weighted spin echo sequence (Fig. 4). The
SSFSE sequence is preferred because it is fast and does
not require breath holding. In addition it allows for the
evaluation of pelvicalyceal system for hydronephrosis
and perinephric fluid collections. The imaging param-
eters are summarized in Table 1.
The second sequence is sagital T1 weighted sequence
is used to assess the position, size, and shape and the
corticomedullary differentiation (CMD) of the renal allo-
graft. The CMD is even better evaluated with T1 WI with fat
saturation or immediate post gadolinium images.
The third sequence is axial T2 fast spin echo sequence
with fat saturation. It is graphically prescribed from the
sagital locator, starting at the iliac crest and extending
down to the level of the sympysis pubis (Fig. 5a). This
sequence is useful to assess perinephric fluid collec-
tions. If the fluid collection is high in signal on both T1
and T2 weighted images (WI) hematoma or abscess is
the possible diagnosis. Peripheral enhancement in T1
weighted images post gadolinium will favor abscess. If
the collection is dark in signal on T1 WI but high on T2 WI,
the possibility of diagnosis lymphocele, seroma, or urinoma
should be considered for the differential diagnosis.
Coronal three-dimensional gadolinium-enhanced
magnetic resonance angiography (3D Gd-MRA) should
encompass the lower abdominal aorta and extend down
to the femoral head. A large field-of-view typically 36 cm
(32–40) should be used. Commonly 38 (28–44) parti-
tions each about 2.4 mm thick (2–3.4 mm) are required
to cover the aorta, iliac arteries, and renal allograft (Fig.
5b). Zero filling is useful to increase interpolated resolu-
tion in the slice direction by two fold (Table 1). The
shortest TR should be used to shorten the scan time to
Figure 3. Coronal MIP reformat from 3D Gd-MRA in a patient who had simultaneous kidney-pancreas transplantation
demonstrating main and accessory arteries supplying the transplant kidney (open arrows) and two arteries supplying the
pancreatic transplants (arrowhead). Notice the multiple aneurysms involving the transplant main renal artery related to prior
pancreatitis of the transplant (small arrow).
Figure 4. Locator SSFSE in coronal plane demonstrating the
renal allograft and a large peritransplant fluid collection com-
pressing the renal allograft (*). A lymphocele was confirmed
with US guided aspiration.
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acquire the 3D data in a single breath-hold (Fig. 6a,c). It
should be 30–40 seconds for patients with a normal
respiratory capacity and less than 30 seconds in pa-
tients who are short of breath. Hyperventilating the
patient and/or giving oxygen is useful to lengthen the
breath-hold capacity. Partial Fourier imaging (0.5 NEX)
is another useful way to shorten the scan time without
sacrificing resolution. However, partial Fourier imaging
increases the risk of having minor ringing artifacts.
Shortening the scan time can also be achieved by
increasing the slice thickness. Shortening the scan time
by using wider bandwidth is less useful since this
incurs a severe SNR penalty. Typically 32 kHz is the
widest bandwidth we use but with dedicated coils, wider
bandwidth might be acceptable.
Three-dimensional phase-contrast MRA (3D PC-
MRA) is then performed in the axial plane prescribed
from the 3D Gd-MRA images (Fig. 7a). Phase-contrast
MRA takes advantage of the previously injected gadolin-
ium contrast to increase the signal-noise ratio (Fig. 6b).
This sequence is useful in assessing the severity of renal
vascular stenosis (Table 2). The high sensitivity of this
sequence has been reported by other investigators;
Silverman et al. reported a sensitivity of phase-contrast
cine MRA of 100% (16–18). The combination of phased-
contrast MRA and 3D Gd-MRA can provide a high level
of confidence in detecting allograft vascular disease.
Additional sequences such as two-dimensional Time-
of-Flight (2D TOF) in the axial plane or occasionally in
coronal plane may be graphically prescribed from the
coronal 3D Gd-MRA to cover the entire allograft to better
evaluate venous anatomy and to look for enhancing
abnormalities (Fig. 7b). Another capability of MR is to
evaluate the allograft blood flow. This is done using
breath-hold cine phase-contrast perpendicular to the
renal artery to measure the transplant renal artery
blood flow. Changes in the time-resolved velocity indi-
cate hemodynamic abnormality (19).
MR renography can be used for the evaluation of the
renal function by acquiring rapid repeated breath-hold
coronal images of the same position of the kidney every
4–6 seconds using unspoiled gradient echo following
the administration of 0.1 mmol/kg of body weight
gadopentate dimeglumine (GD-DTPA). Plotting signal-
intensity vs. time in the cortex and medulla allows
quantitative assessment of the allograft function (20,21).
Ros et al. and Sharma et al. reported good agreement
between the signal intensity curves obtained with MR
renography using gadopentate dimeglumine and the
curves obtained with 99mTc-DTPA renography. They also
found that the global GFR values calculated from the
total body clearance of gadopentate dimeglumine corre-
lated well with the GFR values calculated from total
clearance of 99mTc-DTPA indicating that MR renography
is a feasible technique (22,23).
MR urography provides information about the uri-
nary tract similar to conventional intravenous urogra-
phy; it can be performed using the rapid acquisition
with relaxation enhancement (RARE), half Fourier RARE,
contrast-enhanced three-dimensional gradient echo se-
quence during the excretion phase, or 2D saturation
inversion projection images (24,25). A T1 WI with fat
saturation in axial plane after gadolinium contrast
injection is performed if a mass has been suspected in
the peritransplant region or within the renal allograft on
ultrasound. MRI can characterize the mass and help in
differentiating lymphoproliferative disorder, lymphoma,
infection, hematoma, and infarct.
Table 1













FOV (cm) 40 (32–48) 34 32 (26–44) 34 (30–44) 28 (26–40) 32 (26–44)
TR/TE (ms) ~/180 400/10 3000/102 6.1/1.3 20/7.4 30/7
Flip angle — — 45 35 45
NEX 1 2 4 0.5 (0.5–1) 1 2
Matrix (freq. 3 pha.) 256 3 256 256 3 256 256 3 256 256/(128/256) 256 3 192 256 3 128
Slice (mm) 8 7 8 2.6 (2–4) 2.5 3
Spacing 0 Interleave 2 0 0 0
*FSE 5 fast spin echo, TOF 5 Time-of-Flight, freq 5 frequency encoding, pha 5 phase encoding, FOV 5 field of view, 3D 5 three
dimensional, 2D 5 two dimensional.
Figure 5. Illustration of sagital locator demonstrating position-
ing Volume (a), for Coronal 3D Gd-MRA with tracker position in
the aorta (arrowhead), and (b) the Scanning Range for Axial T2.
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MR IMAGING CHARACTERISTICS OF NORMAL
RENAL TRANSPLANTATION
The perinephric fat that surrounds the renal allograft
should be clear. The renal allograft is uniform in con-
tour with well-defined corticomedullary differentiation
on T1 WI. The renal allograft has intermediate to high
signal on T2 WI and the CMD is not well seen. When
gadolinium contrast is injected, the renal cortex en-
hances first within 10–20 seconds after bolus injection,
followed by medullary enhancement at 20–30 seconds.
The CMD should be assessed during early cortical
enhancement because later there is homogenous en-
hancement of the renal parenchyma. Gadolinium che-
late appears in the collecting system 3–5 minutes after
the start of injection. Concentrated excreted gadolinium
chelate in the collecting system may appear as signal
void or blooming due to T2* effect. On the other hand,
diluted gadolinium chelate produces bright signal.
POSTTRANSPLANTATION COMPLICATIONS
Posttransplantation complications can be grouped as
surgical or medical. Immediate complication attribut-
able to surgical difficulties include renal artery thrombo-
sis or stenosis, renal vein thrombosis, urinary leak, or
lymphocele. Medical complications include rejection,
cyclosporine toxicity, acute tubular necrosis (ATN), in-
fection, and transplantation-related malignancies such
Figure 6. Normal anastomosis of the transplant artery with the right external iliac artery. (a) Coronal oblique MIP reconstruction
of breath-hold 3D Gd-MRA, (b) 3D phase-contrast MRA and (c) venous phase of bolus showing normal transplant vein.
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as posttransplantation lymphoproliferative disorder
(PTLD) and lymphoma.
Renal Artery Stenosis
Allograft renal artery stenosis occurs in 2 to 10% of
cases. It may be caused by intimal hyperplasia at the
site of anastomosis, intraoperative trauma of the trans-
plant artery, or atherosclerosis of the donor vessel. It
may occur as early as 2 days or as late as several years.
Clinically it presents with refractory hypertension
and/or deterioration of renal function. A bruit may be
audible on auscultation. Early diagnosis and successful
treatment of the arterial stenosis prevents premature
loss of the allograft. Percutaneous transluminal angio-
plasty (PTA) is safe and effective and considered the best
approach in managing renal artery stenosis, particu-
larly if the stenosis is not at the anastomosis site (26). A
surgical approach is preferred for the anastomotic steno-
sis but there is a risk of sacrificing the allograft due to
adhesions from prior surgery. Conventional angiogra-
phy or contrast enhanced CT have been infrequently
used for diagnosing renal artery stenosis because many
patients with renal artery stenosis are at higher risk for
iodinated contrast induced renal failure.
Three-dimensional contrast enhanced-MRA (3D Gd-
MRA) is an appropriate substitute for conventional
angiography since it is non-invasive, free of nephrotoxic-
ity, has high spatial resolution, and accurately depicts
the transplant vascular anatomy (4,11–13,27–29). The
combination of 3D phase-contrast MRA and 3D Gd-
MRA increases the accuracy and sensitivity to detect
and grade the severity of the stenosis (Fig. 8a). Our
scheme used to evaluate renal artery stenosis is summa-
rized in Table 2. In cine phase-contrast flow measure-
ments the hemodynamic significance of the stenosis is
indicated by a loss of the early systolic peak in the
velocity profile.
Figure 7. (a) Coronal MIP from 3D Gd-MRA demonstrating positioning Volume for axial 3D PC-MRA. (b) Axial 2D TOF of the pelvis
obtained after 3D Gd-MRA showing iliac vein aneurysm (arrowhead) as complication of prior pancreatitis in patient with
simultaneous kidney-pancreas transplantation.
Table 2







Normal Dephasing Artifact/Inaccurate VENC
Mild stenosis No dephasing Not significant stenosis
Moderate/severe ste-
nosis
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Impairment of arterial flow to the renal transplant
may be caused by stenosis of the allograft vessels
commonly at the site of anastomosis, kinking (Fig. 8b)
or inflow disease proximal to the anastomosis caused by
occlusion or significant stenosis of the common iliac, or
external iliac artery ipsilateral to the allograft (Fig. 9).
Prior transplantation assessment of the pelvic vascular
anatomy with 3D-contrast enhanced MRA may be use-
Figure 8. (a) Severe stenosis at the anastomosis site well depicted in 3D Gd-MRA (arrow). The site of anastomosis was difficult to
assess in DSA due to the orientation and overlapping arteries. (b) 3D Gd-MRA MIP reformat showing kinking of the transplant
renal artery.
Figure 9. Severe stenosis proximal to the transplant artery anastomosis. Coronal MIP from 3D Gd-MRA (left). DSA (right). The
transplant artery and anastomosis are patent.
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ful in high-risk group including diabetics and chroni-
cally hypertensive patients.
There are a few pitfalls that may lead to the false
diagnosis of stenosis or overestimation of a stenosis.
Artifacts caused by metallic surgical clips near the
transplant artery may result in signal drop overlying the
vessel, giving the false impression of stenosis (Fig. 10).
Careful evaluation of the spin echo images and the 3D
Gd-MRA source images will show this signal drop in
both renal artery and vein. Another characteristic find-
ing of the metallic clip artifact is bright signal at the
margin of the signal drop in the soft tissue next to the
renal allograft. Another pitfall may be caused by venous
overlaps due to inaccurate timing of the arterial bolus.
Careful evaluation of the source images and multipla-
nar reformats frequently solve this problem (15).
Renal Artery Thrombosis
Renal artery thrombosis is a rare complication occuring
in 1% of cases. Thrombosis of the main renal artery
usually results in the loss of the renal allograft if not
detected and managed early. It may occur in the first 2
weeks after transplantation. The most common causes
of renal allograft artery thrombosis are hyperacute
rejection, hypercoagulapathy and high cyclosporine
doses. Other less common causes of the allograft renal
artery thrombosis are dissection, malanastomosis, kink-
ing, or torsion of the transplant around its vascular
pedicle (26). Clinically this presents as decrease or no
urine output in a previously functioning renal allograft.
The MR findings of infarcted allograft includes nor-
mal or heterogeneous signal on T1 and T2 WI from
hemorrhagic necrosis (30). If the transplanted kidney
has two renal arteries, segmental infarction may occur
if one artery is occluded. Small infarcts may not cause
abnormal signal in T2 WI. On post-contrast fat satu-
rated T1 WI the infarcted allograft shows no parenchy-
mal enhancement or slight linear enhancement of the
inner renal parenchyma in case of main renal artery
occlusion.
Helenon et al. described variable patterns of allograft
necrosis on post gadolinium enhanced images: small
cortical focal area, large isolated area of infarction,
outer cortical necrosis, cortical necrosis with large
patches, diffuse cortical necrosis, and both cortical and
medullary necrosis (30). Dynamic gadolinium en-
hanced images are more sensitive than T1 and T2 WI in
depicting areas of allograft infarction. It appears as low
signal area relative to the high signal enhancing paren-
chyma. The 3D reformations in multiple planes will
confirm the diagnosis by demonstrating non-visualiza-
tion or absent flow in the transplant renal artery. The
thrombus in the renal artery may be seen as low signal
filling defect within the renal artery.
Renal Transplant Torsion
Torsion occurs when the renal allograft rotates around
its vascular pedicle. It may result in vascular occlusion,
depending on the degree of torsion. This rare complica-
tion has been described in intaraperitoneal transplant
kidneys and may occur early in the postoperative period
Figure 10. Clip artifact produced false positive stenosis. (a) Coronal oblique MIP reformat from 3D Gd-MRA demonstrating signal
drop overlying the transplant artery related to metallic clip artifact giving the false impression of external iliac artery stenosis. (b)
Axial T2 Fast spin echo demonstrating high signal adjacent to the artifactual signal void area produced by the metallic surgical
clip near the anastomosis.
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or as late as 6 months. MRI may show an enlarged kidney
with or without renal hemorrhage. Slow flow in the renal
vessels may be depicted as intravascular signal (31).
Renal Vein Thrombosis
Renal vein thrombosis occurs in 0.3 to 4% of cases.
Frequently seen in the postoperative period. Since the
clinical symptoms are non-specific, therefore the diagno-
sis is often made after the allograft has infarcted.
Thrombosis of the renal vein compromises arterial flow
resulting in allograft infarction (31). MRI demonstrates
an enlarged renal allograft, diminished or absent CMD,
focal areas of parenchymal infarcts. There is no enhance-
ment of the renal allograft on MRA and the thrombosed
renal vein is also not visualized. Subtle linear enhance-
ment of the inner parenchyma of the allograft may be
seen. Subcapsular hemorrhage may also be observed
(Fig. 11).
Lymphocele
The incidence of lymphocele following renal transplanta-
tion occurs between 1 to 18% of cases. It is considered
the most common cause of peritransplant fluid collec-
tion. Lymphoceles that occur in the first month are
often related to the surgery. Late occurrence is often
related to rejection (26). They are frequently located
inferior and medial to the renal allograft. Lymphocele is
of low signal on T1 and high signal on T2 WI. Thin
internal septa may be present (32). The majority of the
lymphoceles are small and asymptomatic. Occasionally
they become large enough to cause urinary obstruction
Figure 11. Renal allograft infarction cased by transplant renal vein thrombosis. a: Sagital T1 WI spin echo. b: Axial T2 WI
demonstrating enlarged renal allograft with loss of normal CMD and sinus fat. The subcapsular hematoma has slightly higher
signal than renal parenchyma in T1 and T2 (arrowhead). c: Axial image obtained after 3D Gd-MRA demonstrating lake of normal
enhancement of the renal allograft with only subtle linear enhancement of the inner medulla and small area in the anterior cortex,
a pattern described in renal infarction.
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by compressing the ureter, the transplant vessels, or
the allograft parenchyma (Fig. 4).
Hematoma
Hemorrhage occurring at the site of the anastomosis
may require urgent surgical intervention. Nonanasto-
motic postoperative hemorrhage is not uncommon (26).
MRI easily diagnoses this complication. The hemor-
rhagic fluid collection appears as high signal in both T1
and T2 WI. The heterogeneous signal of the hemor-
rhagic fluid differentiates it from other causes of peri-
transplant fluid collections. Hemorrhage may occur in the
allograft parenchyma or in the subcapsular or region.
Urinoma
Urinoma is an early complication, occurring early in the
first 5 weeks after transplantation due to leakage of
urine from the anastomotic site at the hilus of the renal
transplant. The incidence of this varies between 3 to
10%. It requires urgent surgical or radiological interven-
tion (32). The signal characteristic of the urinoma is
non-specific low on T1 and high on T2 WI. Lymphocele
and seroma have similar signal intensities. Percutane-
ous aspiration of the fluid collection under ultrasound
guidance will provide the definitive diagnosis. Scintigra-
phy may also help in differentiating urinary leakage
from lymphocele or seroma by detecting free leakage of
the 99mTc-DTPA into the peritoneum.
Cyclosporine Toxicity
The MR findings of cyclosporine toxicity in the renal
allograft are varied. The allograft is often normal in size,
signal, and CMD. However, enlargement of the allograft
and diminished or even absent CMD have been de-
scribed.
Rejection
Allograft rejection results in increase in the T1 shorten-
ing of the renal cortex compared to the medulla and is
related to interstitial edema of the renal cortex. This is
depicted as decreased cortical signal on T1 WI best seen
in the immediate post gadolinium enhanced fat sup-
pressed images or fat suppressed T1 WI. Many authors
consider the loss of CMD as the most consistent MR
finding in allograft rejection (33–35). The degree of CMD
loss roughly corresponds to the severity of the rejection
(36). Hricak et al. described high MRI accuracy in
diagnosing rejection compared to scintigraphy and US,
98%, 75%, and 72%, respectively (37). Unfortunately
this finding is non-specific for rejection and may be seen
in acute tubular necrosis, renal artery thrombosis,
cyclosporine toxicity, and infectious nephritis. Because
of this overlap, some authors considered CMD as being
non-specific to diagnose rejection (38–40). Posttrans-
plant lymphoproliferative disease is another cause of
loss of CMD. This can be differentiated from rejection by
the minimal or lacks of contrast enhancement in post-
transplant lymphoproliferative disease but not with
rejection, but failure of the allograft to enhance after
gadolinium chelate injection may occur in severe ATN
similar to posttransplant lymphoproliferative disease.
The sinus fat may become ill defined in rejection. The
appearance of the rejected allograft on T2 WI is variable
ranging from normal to increased cortical signal relative
to the medulla. Heterogeneous signal intensity or even
low cortical signal has been described. The kidney may
or may not enlarge.
Acute Tubular Necrosis
ATN is most frequently seen in the cadaveric allograft
due to the long ischemia time between harvesting and
Figure 12. Severe acute tubular necrosis. a: 3D Gd-MRA reformat showing patent transplant renal artery. b: A source image
from the second phase 3D Gd-MRA demonstrating lack of renal allograft enhancement compares to the enhancing uterus.
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grafting. This occurs in the first week posttransplanta-
tion but can occur later. ATN has variable appearance
on MR particularly in the cadaveric allograft. The CMD
may be normal, decreased or even absent (Fig. 12).
Geisinger et al. suggested that CMD analysis be of a
little value in ATN of the cadaveric renal transplant (36).
Some authors reported preserved CMD in ATN in living
donor-related allograft, compared to the loss of CMD in
rejection (34,37). However, owing to the overlap between
ATN, cyclosporine toxicity, and rejection, allograft bi-
opsy is frequently needed for definitive diagnosis.
POSTTRANSPLANTATION
LYMPHOPROLIFERATIVE TUMORS
Lymphoreticular malignancies and skin malignancies
have been reported to be more frequent in immunosup-
pressed patients than in the general population (42).
Malignant lymphoma (commonly non-Hodgkin type)
and cyclosporine-induced lymphoproliferative disorder
(PTLD) have been described post kidney transplanta-
tion. The incidence of PTLD is 2%. It almost always
occurs in Epstein-Barr virus positive patients (44). It
commonly occurs 2 to 8 months after transplantation, it
may regress or completely disappear after reduction of
the cyclosporine dose. The sites of involvement are
lymph nodes, gastrointestinal tract, lungs, and brain.
The allograft may be affected but to a lesser degree than
with posttransplantation lymphoma (43,44). Ali et al.
described predilection of PTLD to occur as a mass in the
renal hilum that encases the hilar vessels of the renal
allograft. When renal parenchyma is involved, it tends
to be as multiple lesions. PTLD appears as hypointense
mass on T1 and T2 WI with minimal enhancement after
gadolinium contrast (45). Using MRI as complementary
to ultrasound or CT may be useful to diagnose this
entity. Other abnormalities that can be difficult to be
differentiated from PTLD are lymphoma, rejection, and
peritransplant hematoma.
Contrast enhancement may favor peritransplant PTLD
over hematoma particularly if there is encasement of
the renal hilar vessels.
SUMMARY
MR angiography is a reliable diagnostic modality in the
evaluation of renal allograft vascular complications. It
may be used as a primary modality if vascular complica-
tion is highly suspected or following ultrasound MRI is
complementary to ultrasound or computed tomography
in the characterization of abnormalities to reach a
specific diagnosis.
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